Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEL-REC
NCT07553143Recruiting
- Sponsor
- Armed Forces Medical Institute
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in impaired postoperative quality of recovery (PQR) comparing Melatonin Group with Placebo Group (2 arms). Primary endpoint: Quality of Recovery-15 total score at 24 hours. Started May 2026; status: recruiting.
02
Drugs
melatonin
03
Conditions
impaired postoperative quality of recovery (PQR)
Beyond the preview
Go deeper on NCT07553143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553143.